A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation
Journal of Allergy and Clinical Immunology: Global · 2024-08 · 3 (3) · 100249
DOI: 10.1016/j.jacig.2024.100249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2024-08. Verfasst von Yuki Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology.
Abstract (Originalsprache)
Background
The KIT receptor tyrosine kinase and its ligand, stem cell factor (SCF), control proliferation and survival of mast cells. Thus, targeting KIT signaling may show promise for the treatment of allergic diseases involving mast cells. Recently, we discovered a new compound, MOD000001, as a potential small-molecule KIT kinase inhibitor by using an in silico approach.
Objective
We sought to determine whether MOD000001 is highly selective to KIT, inhibits KIT signaling in mast cells, and affects IgE-mediated mast cell activation.
Methods
The interaction of MOD000001 with 468 human kinases and its inhibitory activity against KIT were profiled and evaluated by using KINOMEscan (Discover X/Eurofins Corporation, Fremont, Calif) and cell-free kinase assays, respectively. The effects of MOD000001 on SCF-dependent signaling were examined by using primary mouse and human mast cells. The effects of MOD000001 on SCF-induced degranulation and passive cutaneous anaphylaxis reaction were examined in mice.
Results
MOD000001 interacted with KIT and inhibited KIT kinase activity with high selectivity. MOD000001 suppressed SCF-induced KIT signaling in mouse and human mast cells and in mice. Passive cutaneous anaphylaxis reaction was suppressed in mice treated with MOD000001 both for a short-term (1 week) and for a long-term (7 weeks). Mice treated with MOD000001 for a long-term, but not for a short-term, showed skin mast cell reduction.
Conclusions
MOD000001 is a highly selective KIT inhibitor that can suppress IgE-mediated mast cell activation in vivo. MOD000001 may do so by reducing tissue mast cell numbers or by other unknown mechanisms. The findings suggest potential benefits of MOD000001 for allergic diseases involving IgE-mediated mast cell activation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
- Alivexis, Inc, Tokyo, Japan.
- Aurigene Oncology, Ltd, Bangalore, India.
- Yamanashi GLIA Center, University of Yamanashi, Yamanashi, Japan.
- Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
Zitieren
APA
Nakamura, Y., Urakami, T., Ishimaru, K., Vuong Tran, N. Q., Shimizu, T., Sinko, W., Takahashi, T., Marappan, S., Narayanan, K., Poddutoori, R., Terada, Y., & Nakao, A. (2024). A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation. Journal of Allergy and Clinical Immunology: Global, 3(3), 100249. https://doi.org/10.1016/j.jacig.2024.100249
Vancouver
Nakamura Y, Urakami T, Ishimaru K, Vuong Tran NQ, Shimizu T, Sinko W, et al. A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation. Journal of Allergy and Clinical Immunology: Global. 2024;3(3):100249. doi:10.1016/j.jacig.2024.100249
BibTeX
@article{Nakamura2024,
author = {Nakamura, Yuki and Urakami, Takeo and Ishimaru, Kayoko and Vuong Tran, Nguyen Quoc and Shimizu, Takafumi and Sinko, William and Takahashi, Taisuke and Marappan, Sivapriya and Narayanan, Kishore and Poddutoori, Ramulu and Terada, Yoh and Nakao, Atsuhito},
title = {A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation},
journal = {Journal of Allergy and Clinical Immunology: Global},
year = {2024},
volume = {3},
number = {3},
pages = {100249},
doi = {10.1016/j.jacig.2024.100249}
}
EUVIMED